Meritage Portfolio Management »

Vertex Pharmaceuticals Incorporated shares owned by Meritage Portfolio Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Meritage Portfolio Management from 13F filings

Historical chart of Meritage Portfolio Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Meritage Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Meritage Portfolio Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 38k 418.01
2023-12-31 $16M 39k 406.88
2023-09-30 $8.5M 24k 347.75
2023-06-30 $8.6M 24k 351.93
2023-03-31 $8.0M 25k 315.05
2022-12-31 $7.5M 26k 288.79
2022-09-30 $7.8M 27k 289.54

More positions owned by Meritage Portfolio Management

Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc Cl A Common (GOOGL)
Broadcom Common (AVGO)
Amazon Common (AMZN)
Novo-nordisk A S Common (NVO)
Asml Holding Nv Common (ASML)
Cadence Design Systems Common (CDNS)
Fortinet Common (FTNT)
Cheniere Energy Common (LNG)
Pioneer Nat Res Common (PXD)
Mastercard Common (MA)
Spdr S&p 500 Value Etf Other Equities (SPYV)
Ametek Common (AME)
Kla Corporation Common (KLAC)

View all positions for Meritage Portfolio Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated